IBDEI2VD ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45773,1,4,0)
 ;;=4^F17.221
 ;;^UTILITY(U,$J,358.3,45773,2)
 ;;=^5003371
 ;;^UTILITY(U,$J,358.3,45774,0)
 ;;=F17.223^^172^2281^3
 ;;^UTILITY(U,$J,358.3,45774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45774,1,3,0)
 ;;=3^Nicotine Dependence,Chewing Tobacco w/ Withdrawal
 ;;^UTILITY(U,$J,358.3,45774,1,4,0)
 ;;=4^F17.223
 ;;^UTILITY(U,$J,358.3,45774,2)
 ;;=^5003372
 ;;^UTILITY(U,$J,358.3,45775,0)
 ;;=F17.228^^172^2281^4
 ;;^UTILITY(U,$J,358.3,45775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45775,1,3,0)
 ;;=3^Nicotine Dependence,Chewing Tobacco w/ Oth Disorders
 ;;^UTILITY(U,$J,358.3,45775,1,4,0)
 ;;=4^F17.228
 ;;^UTILITY(U,$J,358.3,45775,2)
 ;;=^5003373
 ;;^UTILITY(U,$J,358.3,45776,0)
 ;;=Z51.81^^172^2282^19
 ;;^UTILITY(U,$J,358.3,45776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45776,1,3,0)
 ;;=3^Therapeutic Drug Monitoring
 ;;^UTILITY(U,$J,358.3,45776,1,4,0)
 ;;=4^Z51.81
 ;;^UTILITY(U,$J,358.3,45776,2)
 ;;=^5063064
 ;;^UTILITY(U,$J,358.3,45777,0)
 ;;=Z79.01^^172^2282^6
 ;;^UTILITY(U,$J,358.3,45777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45777,1,3,0)
 ;;=3^Long Term Current Use of Anticoagulants
 ;;^UTILITY(U,$J,358.3,45777,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,45777,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,45778,0)
 ;;=Z79.02^^172^2282^7
 ;;^UTILITY(U,$J,358.3,45778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45778,1,3,0)
 ;;=3^Long Term Current Use of Antithrombotics/Antiplatelets
 ;;^UTILITY(U,$J,358.3,45778,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,45778,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,45779,0)
 ;;=Z79.1^^172^2282^10
 ;;^UTILITY(U,$J,358.3,45779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45779,1,3,0)
 ;;=3^Long Term Current Use of NSAIDs
 ;;^UTILITY(U,$J,358.3,45779,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,45779,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,45780,0)
 ;;=Z79.2^^172^2282^5
 ;;^UTILITY(U,$J,358.3,45780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45780,1,3,0)
 ;;=3^Long Term Current Use of Antibiotics
 ;;^UTILITY(U,$J,358.3,45780,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,45780,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,45781,0)
 ;;=Z79.82^^172^2282^8
 ;;^UTILITY(U,$J,358.3,45781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45781,1,3,0)
 ;;=3^Long Term Current Use of Aspirin
 ;;^UTILITY(U,$J,358.3,45781,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,45781,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,45782,0)
 ;;=Z79.51^^172^2282^9
 ;;^UTILITY(U,$J,358.3,45782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45782,1,3,0)
 ;;=3^Long Term Current Use of Inhaled Steroids
 ;;^UTILITY(U,$J,358.3,45782,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,45782,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,45783,0)
 ;;=Z79.52^^172^2282^11
 ;;^UTILITY(U,$J,358.3,45783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45783,1,3,0)
 ;;=3^Long Term Current Use of Systemic Steroids
 ;;^UTILITY(U,$J,358.3,45783,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,45783,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,45784,0)
 ;;=Z91.19^^172^2282^12
 ;;^UTILITY(U,$J,358.3,45784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45784,1,3,0)
 ;;=3^Non-Compliance w/ Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,45784,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,45784,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,45785,0)
 ;;=Z87.01^^172^2282^15
 ;;^UTILITY(U,$J,358.3,45785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45785,1,3,0)
 ;;=3^Personal Hx of Pneumonia,Recurrent
